Bioethics News

Anti-Rejection Drug Prices Cut by 65%

May 19, 2016

(Times of India) – For a patient in need of an organ transplant, finding the right donor and undergoing the procedure is just half the battle won. Thereafter, living with the foreign organ comes with a huge price tag in way of immuno suppressants or antirejection drugs which the recipient has to depend on for the rest of his life. In a huge respite for such patients , the National Pharmaceutical Pricing Authority ( NPPA ) has reduced the rates of these drugs, with the cost of most-widely used Tacrolimus being slashed by 60-65%.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.